NCT01175083View on ClinicalTrials.gov

Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2011

Primary Completion Date

January 17, 2013

Study Completion Date

May 23, 2013

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

GSK1024850A (Synflorix)

2, 3 or 4 intramuscular injection

BIOLOGICAL

Tritanrix-HepB/Hib

Intramuscular injection, 4 doses

BIOLOGICAL

Polio Sabin

4 oral doses

Trial Locations (1)

Unknown

GSK Investigational Site, Ouagadougou

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY